An antibiotic from an uncultured bacterium binds to an immutable target

Area of Science:

• Microbiology
• Drug Discovery
• Biochemistry

Background:

• Antimicrobial resistance (AMR) is a significant global health threat, leading to high mortality rates.
• The emergence of drug-resistant bacterial pathogens necessitates the discovery of novel antibiotics with new mechanisms of action.

Purpose of the Study:

• To report the discovery and characterization of clovibactin, a novel antibiotic effective against drug-resistant Gram-positive bacteria.
• To elucidate the unique mechanism of action of clovibactin in inhibiting bacterial cell wall synthesis.

Main Methods:

• Isolation and characterization of clovibactin from uncultured soil bacteria.
• Biochemical assays, solid-state nuclear magnetic resonance (ssNMR), and atomic force microscopy (AFM) to determine the mode of action.
• Investigation of clovibactin's interaction with peptidoglycan precursors.

Main Results:

• Clovibactin demonstrates potent activity against drug-resistant Gram-positive pathogens with no detectable resistance.
• The antibiotic targets the pyrophosphate moiety of essential peptidoglycan precursors (C55PP, lipid II, lipid IIIWTA).
• Clovibactin's unique hydrophobic binding prevents resistance by bypassing variable precursor structures and forming supramolecular fibrils on bacterial membranes.

Conclusions:

• Clovibactin represents a promising new class of antibiotics with a novel mechanism that circumvents existing resistance pathways.
• Its ability to target essential precursors without inducing resistance offers a potential strategy for developing next-generation therapeutics against bacterial infections.